NEW YORK, July 26 (UPI) -- A case involving an agreement to keep a low-priced generic copy of a drug off the market may be headed for the U.S. Supreme Court, an anti-trust expert says.
Eleanor M. Fox, a professor at the New York University law school, said a ruling by a federal appeals court in Philadelphia that the agreement is anti-competitive conflicts with at least three other federal appeals court rulings, The New York Times reported Thursday.